Xilio Therapeutics (XLO) Accounts Payables (2020 - 2026)
Xilio Therapeutics (XLO) reported Accounts Payables of $2.32 million for Q2 2026, down 43.5% from $4.1 million a year earlier but up 117.6% from the prior quarter.
Xilio Therapeutics (XLO) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Xilio Therapeutics posted Accounts Payables of $3.17 million, up 23.1% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of -10.3% (FY2020 to FY2025).
- By year, Accounts Payables came in at $2.57 million in FY2024 (+145.1%), $1.05 million in FY2023 (-66.4%), $3.13 million in FY2022 (-0.6%) and $3.14 million in FY2021 (-42.2%).
- Five-year quarterly Accounts Payables spans a low of $746,000 in Q1 2024 and a high of $4.1 million in Q2 2025.
- Year over year, Accounts Payables gained in five of the last eight quarters, with growth averaging 75.3%.
- The high point for year-over-year Accounts Payables in five years was Q2 2025 (growth of 224.1%); the low point was Q4 2023 (a decline of 66.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.06 million (Q1 2026), $3.17 million (Q4 2025) and $2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Xilio Therapeutics | 157.76 Mn | -369.91 Mn | - | 2.32 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.32 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 3.17 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 972,000.00 |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 746,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 945,000.00 |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 2.32 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 3.82 Mn |
Xilio Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=XLO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();